Behind the Breakthroughs

Behind the Breakthroughs

By Inside Precision MedicineScienceMedicineHealth & FitnessLife Sciences
Download on the App Store

Behind the Breakthroughs episodes

  • Michael Severino: Towards In Vivo Genome Editing of Humans

    Michael Severino, MD, discusses the approaches for developing "genome writers" at Tessera Therapeutics, where he joined as CEO in 2022, and the advantages of performing in vivo genome editing over ex vivo approaches. Severino explains where the company is in utilizing its genome writing platform to perform edits in vivo on its journey toward the clinic.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein, PhD

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack


    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    34 min
  • Jane Gibson: AMP and Molecular Diagnostics’ Existential Crisis

    This special edition episode for the upcoming Association for Molecular Pathology (AMP) annual meeting in Vancouver, Jane Gibson, PhD, opens up the dialogue about how the evolving field of molecular pathology is taking on major challenges, including how the FDA’s ruling on laboratory developed tests (LDTs) is affecting clinical labs. Dr. Gibson is a Professor of Pathology at the University of Central Florida, Editor-in-chief of Genetic Testing and Molecular Biomarkers, and President Elect of AMP.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein, PhD

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

     

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    28 min
  • Helen Sabzevari: How to Turn $1,000,000 CAR Ts into “Real” Precision Medicines

    Helen Sabzevari, PhD, President and CEO of Precigen, discusses the barriers to implementing cell and gene therapies that impede the accessibility and implementation of these precision medicines. Dr. Sabzevari also explains how key cell and gene therapy platforms and tools can provide safety measures, such as guardrails to cellular toxicity, and address cost by offering “off-the-shelf” efficient gene delivery vectors that can be used on-site, cutting out centralized manufacturing.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein, PhD

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

     

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    31 min
  • Luca Quagliata: Weaving Genomic Profiling into Personalized Cancer Care


    Luca Quagliata, PhD, global head of medical affairs for clinical NGS and oncology at Thermo Fisher Scientific, shares how his career has been intertwined with precision medicine, beginning with his time as a student in Italy during the early 2000s. Quagliata examines the significance of genomic profiling within the cancer care continuum, outlining the essential steps and touchpoints necessary to ensure the accessibility of personalized oncology treatment for all individuals.

     

    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    7Q4XKpRvPIvPZPkK6RbZ


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein, PhD

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    17 min
  • Geoff Oxnard: The Tipping Point for Adopting Precision Medicine

    In the premiere episode of Behind the Breakthroughs, Geoff Oxnard, MD, VP of Clinical Development at Lilly and a Thoracic Oncologist at Boston Medical Center, shares his journey in precision medicine, beginning with his introduction to genetic testing as a Medical Oncology Fellow at Memorial Sloan-Kettering Cancer Center and as an academic researcher. Oxnard discusses how differences in impact and reach influenced his decision to move from academia to industry. He also explains how the adoption of precision testing in the United States is influenced by perspective rather than accessibility. This episode also covers flexible enrollment in clinical trials, adapting to patient perspectives on clinical research as care, the current state of precision medicine, particularly precision oncology, in the United States and elsewhere, and more.

     

    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein, PhD

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    35 min

About Behind the Breakthroughs

From the publisher's feed

Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what…

More shows like Behind the Breakthroughs

Nature Podcast by Springer Nature Limited

Nature Podcast

767 Listeners

The Daily by The New York Times

The Daily

112,285 Listeners

Call Me Back - with Dan Senor by Ark Media

Call Me Back - with Dan Senor

3,228 Listeners

Unexplainable by Vox

Unexplainable

2,304 Listeners

Touching Base by Genetic Engineering & Biotechnology News (GEN)

Touching Base

4 Listeners